STIM Stock Analysis: Buy, Sell, or Hold?
STIM - Neuronetics, Inc. Common Stock
$1.77
-0.02 (-1.12%)
▼
5d:
+14.19%
30d:
+35.11%
90d:
+27.34%
HOLD
MODERATE Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 04, 2026
19d
Get Alerted When STIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: STIM is 12.7% above its trading range ($1.57). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: STIM is 12.7% above its trading range ($1.57). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: STIM is currently trading at $1.77, which is considered extended relative to its 30-day fair value range of $1.20 to $1.57.
Technical Outlook: Technically, STIM is in a downtrend. The price is approaching resistance at $1.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+144.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STIM is in a downtrend. The price is approaching resistance at $1.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: STIM has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $4.33 (+144.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.20 -
$1.57
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+12.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 144.8% below Wall St target ($4.33)
Trading Range Analysis
30-Day Trading Range
$1.20 -
$1.57
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.20
Resistance Level
$1.74
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.26
Wall Street Target
$4.33
(+144.8%)
Revenue Growth (YoY)
7.8%
Profit Margin
-24.5%
Share & Embed Analysis
Last updated: July 14, 2026 11:10 PM ET
Data refreshes hourly during market hours. Next update: 12:10 AM
Data refreshes hourly during market hours. Next update: 12:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STIM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorey Chernett
BUY
100000 shares
2026-04-20
Jorey Chernett
BUY
169472 shares
2026-03-20
Jorey Chernett
BUY
450000 shares
2026-03-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 64 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 50 HOLD |
